Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Cellectis S.A. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −5 vs. Q1 2026
- Shares held
- 9.48M
- −767.5K (−7.5%) vs. Q1 2026
- Total value
- $28.4M
- −$4.04M (−12.4%) vs. Q1 2026
- New holders
- 3
- 2 more added
- Sold out
- 8
- 9 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM Advisors, LLC | 6 | $18 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 13 | $39 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 50 | $142 | 0.00% | +50 | New |
| Caitong International Asset Management Co., Ltd | 49 | $147 | 0.00% | +49 | New |
| Larson Financial Group LLC | 75 | $225 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 100 | $300 | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 463 | $1.39K | 0.00% | −271−36.9% | Reduced |
| POM Investment Strategies, LLC | 495 | $1.49K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 500 | $1.50K | 0.00% | 00.0% | Unchanged |
| Atlantic Union Bankshares Corp | 1,500 | $4.50K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,558 | $5.00K | 0.00% | +1,558 | New |
| Wells Fargo & Company | 3,150 | $9.45K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 3,600 | $10.8K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 4,500 | $13.5K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 12,282 | $36.8K | 0.00% | −3,987−24.5% | Reduced |
| Rhumbline Advisers | 14,328 | $43.0K | 0.00% | −757−5.0% | Reduced |
| Delaney Dennis R | 24,000 | $72.0K | 0.02% | 00.0% | Unchanged |
| UBS Group AG | 33,926 | $101.8K | 0.00% | +4,152+13.9% | Added |
| BNP Paribas Arbitrage, SA | 40,100 | $120.3K | 0.00% | −900−2.2% | Reduced |
| Susquehanna International Group, LLP | 50,453 | $151.4K | 0.00% | −15,489−23.5% | Reduced |
| LPL Financial LLC | 84,415 | $253.2K | 0.00% | +70+0.1% | Added |
| Morgan Stanley | 85,455 | $256.4K | 0.00% | −1,321−1.5% | Reduced |
| BlackRock, Inc. | 225,444 | $676.3K | 0.00% | −116,079−34.0% | Reduced |
| Nomura Asset Management International Inc. | 226,875 | $681.0K | 0.00% | 00.0% | Unchanged |
| UBS Asset Management Americas Inc | 2,644,881 | $7.93M | 0.00% | −533,739−16.8% | Reduced |
| Long Focus Capital Management, LLC | 2,741,853 | $8.23M | 0.34% | −2,245−0.1% | Reduced |
| B Group, Inc. | 3,281,501 | $9.84M | 5.59% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −44,315−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −41,112−100.0% | Sold out |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −10,094−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,797−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −944−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −224−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −97−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |